Search alternatives:
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
09 0 » 0 0 (Expand Search), 01 0 (Expand Search), 05 0 (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
09 0 » 0 0 (Expand Search), 01 0 (Expand Search), 05 0 (Expand Search)
-
221
-
222
-
223
-
224
-
225
Patients’ clinicopathological characteristics.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
226
Oncologic results.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
227
Perioperative parameters.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
228
Perioperative complications.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
229
-
230
Microstructure and Dielectric Behavior of Ytterbium Doped BaZr0.1Ti0.9O3 Ceramics
Published 2022“…<div><p>BaZr0.1Ti0.9O3 ceramics of perovskite structure are prepared by solid state reaction method with addition of x Yb2O3 (x= 0.0, 0.1, 0.3, 0.5 and 0.7 mol%), respectively, and their dielectric properties are investigated. …”
-
231
-
232
-
233
-
234
-
235
-
236
Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF
Published 2021“…No serious adverse events occurred. We observed numerical decreases of all infiltrating cell subtypes at week 12, reaching statistical significance for CD68+ sublining macrophages. …”
-
237
-
238
-
239
-
240